HRDÝ, Ondřej, Miloš DUBA, Andrea DOLEZELOVA, Ivana ROŠKOVÁ, Martin HLAVATÝ, Rudolf TRAJ, Vít BÖNISCH, Martin SMRČKA and Roman GÁL. Effects of goal-directed fluid management guided by a non-invasive device on the incidence of postoperative complications in neurosurgery: a pilot and feasibility randomized controlled trial. PERIOPERATIVE MEDICINE. London: BMC, 2023, vol. 12, No 1, p. 1-9. ISSN 2047-0525. Available from: https://dx.doi.org/10.1186/s13741-023-00321-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effects of goal-directed fluid management guided by a non-invasive device on the incidence of postoperative complications in neurosurgery: a pilot and feasibility randomized controlled trial
Authors HRDÝ, Ondřej (203 Czech Republic, belonging to the institution), Miloš DUBA (203 Czech Republic, guarantor, belonging to the institution), Andrea DOLEZELOVA (203 Czech Republic), Ivana ROŠKOVÁ (703 Slovakia, belonging to the institution), Martin HLAVATÝ (203 Czech Republic, belonging to the institution), Rudolf TRAJ (703 Slovakia, belonging to the institution), Vít BÖNISCH (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution) and Roman GÁL (203 Czech Republic, belonging to the institution).
Edition PERIOPERATIVE MEDICINE, London, BMC, 2023, 2047-0525.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.600 in 2022
RIV identification code RIV/00216224:14110/23:00131383
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/s13741-023-00321-3
UT WoS 001019955700001
Keywords in English Complications; Goal-directed therapy; Hemodynamic monitoring; Neuro-anesthesia; Neurosurgery; Postoperative outcome
Tags 14110224, 14110233, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 9/8/2023 08:25.
Abstract
BackgroundThe positive effects of goal-directed hemodynamic therapy (GDHT) on patient-orientated outcomes have been demonstrated in various clinical scenarios; however, the effects of fluid management in neurosurgery remain unclear. Therefore, this study was aimed at assessing the safety and feasibility of GDHT using non-invasive hemodynamic monitoring in elective neurosurgery. The incidence of postoperative complications was compared between GDHT and control groups.MethodsWe conducted a single-center randomized pilot study with an enrollment target of 34 adult patients scheduled for elective neurosurgery. We randomly assigned the patients equally into control and GDHT groups. The control group received standard therapy during surgery and postoperatively, whereas the GDHT group received therapy guided by an algorithm based on non-invasive hemodynamic monitoring. In the GDHT group, we aimed to achieve and sustain an optimal cardiac index by using non-invasive hemodynamic monitoring and bolus administration of colloids and vasoactive drugs. The number of patients with adverse events, feasibility criteria, perioperative parameters, and incidence of postoperative complications was compared between groups.ResultsWe successfully achieved all feasibility criteria. The GDHT protocol was safe, because no patients in either group had unsatisfactory brain tissue relaxation after surgery or brain edema requiring therapy during surgery or 24 h after surgery. Major complications occurred in two (11.8%) patients in the GDHT group and six (35.3%) patients in the control group (p = 0.105).ConclusionsOur results suggested that a large randomized trial evaluating the effects of GDHT on the incidence of postoperative complications in elective neurosurgery should be safe and feasible. The rate of postoperative complications was comparable between groups.
Links
MUNI/A/1421/2022, interní kód MUName: Vývoj metod a instrumentace pro analýzu biologicky významných látek 2023
Investor: Masaryk University
PrintDisplayed: 6/5/2024 02:26